Galderma Group, a pure-play dermatology firm, has announced the price range, published its prospectus and started the book-building process, as part of its intention...
Ampersand Capital Partners, a mid-market private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, has acquired UK-based Specac,...
Novo Holdings, the holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, reported total income and investment...
France based ProductLife Group (PLG), a provider of healthcare consulting and outsourcing services, is strengthening its capability to provide global digital consulting services with...
Sweden-based TFS HealthScience (TFS), a full service (CRO), has expanded into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia.
The APAC...
Inflexion, a European mid-market private equity firm, has announced the final close of Inflexion Partnership Capital Fund III at its hard cap of £1.75bn...
Aspire Pharma, a specialty generics business, has supplemented its organic growth with the acquisition of Cenoté Pharma, a category specialist in carnitine deficiencies.
Financial terms...
Vimian, a global animal health company covering four areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services, has announced its intention to raise up to...
Life science investor, Flerie Invest, has passed the threshold for a mandatory bid for Lipum, a clinical stage biopharmaceutical company specialized in discovery and...
Limerston Capital, a private equity firm targeting UK businesses, has announced the final close of its second fund, Limerston Capital Partners II, with total...